Editors' ChoiceCardiovascular Disease Cutting choline conversion in commensals to treat cardiovascular disease Louis J. CohenDivision of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Email: louis.cohen{at}mssm.edu See allHide authors and affiliations Science Translational Medicine 05 Sep 2018:Vol. 10, Issue 457, eaav0333DOI: 10.1126/scitranslmed.aav0333 Louis J. Cohen Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Email: Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: louis.cohen@mssm.edu Article Info & Metrics eLetters Article Information vol. 10 no. 457 DOI: https://doi.org/10.1126/scitranslmed.aav0333 Published By: American Association for the Advancement of Science Print ISSN: 1946-6234 Online ISSN: 1946-6242 History: . Copyright & Usage: Copyright © 2018, American Association for the Advancement of Science Author Information Louis J. CohenDivision of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Email: louis.cohen{at}mssm.edu Altmetric Article usage Article lifetimeLast 6 monthsThis monthArticle usage: August 2018 to January 2021 AbstractFullPdf Aug 2018040 Sep 2018133010 Oct 201801990 Nov 201801040 Dec 201801120 Jan 20198950 Feb 201916700 Mar 201916800 Apr 20196620 May 201931800 Jun 201912081 Jul 20197970 Aug 20198610 Sep 20192572 Oct 20194490 Nov 201914811 Dec 20194661 Jan 20204640 Feb 20205560 Mar 20201270 Apr 202022950 May 20203220 Jun 20200260 Jul 20203570 Aug 20201360 Sep 20202430 Oct 20201390 Nov 20203200 Dec 20204450 Jan 20212120 View Full Text
Cutting choline conversion in commensals to treat cardiovascular disease By Louis J. Cohen Science Translational Medicine05 Sep 2018 A strategy to selectively target a microbial enzyme reduces the production of a metabolite linked to the development of cardiovascular disease.
Cutting choline conversion in commensals to treat cardiovascular disease By Louis J. Cohen Science Translational Medicine05 Sep 2018 A strategy to selectively target a microbial enzyme reduces the production of a metabolite linked to the development of cardiovascular disease.